Bio Green Med Solution (BGMS) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Bio Green Med Solution (BGMS) over the last 9 years, with Q3 2025 value amounting to -$1.31.
- Bio Green Med Solution's EPS (Weighted Average and Diluted) rose 9700.91% to -$1.31 in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.58, marking a year-over-year increase of 9975.02%. This contributed to the annual value of -$504.3 for FY2024, which is 9214.39% up from last year.
- Per Bio Green Med Solution's latest filing, its EPS (Weighted Average and Diluted) stood at -$1.31 for Q3 2025, which was up 9700.91% from -$0.98 recorded in Q2 2025.
- Bio Green Med Solution's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.42 during Q1 2022, with a 5-year trough of -$6417.8 in Q4 2023.
- For the 5-year period, Bio Green Med Solution's EPS (Weighted Average and Diluted) averaged around -$372.0, with its median value being -$1.14 (2025).
- As far as peak fluctuations go, Bio Green Med Solution's EPS (Weighted Average and Diluted) plummeted by 2464090.21% in 2023, and later soared by 9977.73% in 2024.
- Quarter analysis of 5 years shows Bio Green Med Solution's EPS (Weighted Average and Diluted) stood at -$0.51 in 2021, then tumbled by 4986.27% to -$25.94 in 2022, then plummeted by 24640.9% to -$6417.8 in 2023, then surged by 99.78% to -$14.29 in 2024, then soared by 90.83% to -$1.31 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$1.31 for Q3 2025, versus -$0.98 for Q2 2025 and -$14.29 for Q4 2024.